🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Royalty Pharma plc (RPRX)
NASDAQ: RPRX · Real-Time Price · USD
68.45
+0.73 (1.08%)
At close: Nov 20, 2026, 4:00 PM EST
67.65
-0.80 (-1.17%)
After-hours: Nov 20, 2026, 7:48 PM EST

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15
Cystic Fibrosis Franchise Revenue
853.84M828.18M826.21M
Tremfya Revenue
231.04M152.94M147.14M
Evrysdi Revenue
225.62M206.97M224.43M
Voranigo Revenue
177.70M154.42M46.15M
Trelegy Revenue
160.20M154.10M146.92M
Tysabri Revenue
112.67M116.88M124.82M
Other Products Revenue
711.99M647.67M633.76M
Total Income from Financial Royalty Assets
2.47B2.26B2.15B
Other Royalty Income and Revenue
143.75M117.04M114.15M
Revenue (Other)
-177.70M-154.42M-46.15M
Revenue (Total)
2.62B2.38B2.26B

Key Performance Indicators

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15
Portfolio Receipts
3.46B3.25B2.80B